TruGenomix, BlueBee Launch Behavioral Health Partnership Sparked by COVID-19

The companies said they will train, model, and expand insights continuously using machine learning and artificial intelligence, with the goal of enabling early identification of people at high risk for PTSD and other behavioral health conditions based on their biomarkers.
One of the major scientific crusades in oncology has been to identify and validate biomarkers associated with recurrent breast cancer. [iStock / royaltystockphoto]

Analysis of 100 Studies Reveals 32 New Sites of Genetic Variation Linked to Breast...

Researchers used data collected by the UK-based Breast Cancer Association Consortium over the last 15 years employing new analytical methods to identify variants that can have different effects for different types of cancer.
Autism spectrum disorder, conceptual illustration

New Research Points to Common Gene Expression Profile of Autism Spectrum Disorder

The results indicate that while the DNA of individuals with autism may harbor different alterations, the activity of these genes is similar in people with the disorder, and differs from that of the same genes in the brains of people without autism.

PrecisionLife’s AI Platform Identifies 59 Drug Candidates with Potential vs. Sepsis in COVID-19

According to PrecisionLife, the 59 drug candidates could be studied in future drug trials and repurposing projects—and also hold potential as high-risk biomarkers for COVID-19.
Clinical OMICs Keynote Webinar lead image

Newborn Genomic Screening: In Sickness and In Health

In this inaugural Clinical OMICs Keynote webinar, we are proud to host two renowned leaders in the field of genomic medicine, Drs Stephen Kingsmore and Robert Green, who will discuss their pioneering work in the field of newborn genome sequencing and analysis.
A newborn in the hospital's maternity ward

Biomarker in Cerebrospinal Fluid of Infants May Predict Development of Autism

The study showed that the hormone vasopressin was present at much lower levels in the CSF of 0–3-month-old babies who were later diagnosed with ASD than it was in CSF samples from infants who weren’t subsequently diagnosed with ASD.

Rare Gene Discovered That Nearly Doubles Risk of Developing a Neurodegenerative Disease

The researchers found that rare variation in the gene TET2 nearly doubled the risk of developing diseases like Alzheimer disease (AD), amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD).

Biobanks Play Important Role in Fight Against COVID-19

Issues related to patient sample collection, processing, and analyses have long been important factors in handling the response to emerging infectious diseases.
Timothy Chan

The Accelerating Race for Immunotherapy Biomarkers

As the market for immunotherapies grows, doctors’ interest in diagnostics to guide more precise treatment increases.
Celselect Slide

Tapping into the Potential of Circulating Tumor Cells

The detection of CTCs with the Genesis System has several potential clinical research applications in cancer. This technology could guide upfront treatment decisions, predict which tumors will metastasize, and identify therapeutic response early in the treatment cycle, thereby allowing decisions about whether to stop or continue their course of therapy.
Scroll Up